ABSTRACT
INTRODUCTION
Stress-evoked release of ATP from the basolateral surface of the bladder wall was initially shown by a change to the transmural pressure (1) . Subsequently, ATP release has been measured due to lateral stretch of mucosal strips or urothelial cell cultures (2) (3) (4) , as well as exposure of urothelial cells to hypotonic solutions to cell swelling (5, 6) . ATP release is increased in cells from overactive bladders (2, 3, 7) , itself reduced after botulinum toxin treatment (8) , and exposure to ATP itself suggesting an autocatalytic process (6) . It has been proposed that this ATP pool eventually activates adjacent afferent nerves thus providing a sensory mechanism to relay information about bladder volume (9, 10) . This hypothesis is supported by a reduction of afferent nerve firing on bladder filling in P2X3 knockout mice (11) .
However, a number of key questions remain unanswered including: the processes that regulate stress-induced ATP release, as well as the cellular pathways that mediate ATP release. An involvement of cholinergic pathways is possible as acetylcholine is also released from the bladder wall on stretch (12) and from cultured urothelial cells exposed to a hypotonic solution (13) . Anticholinergic agents, used clinically to treat the overactive bladder, are effective in the filling phase of the micturition cycle as they increase bladder capacity and decrease sensations of urgency (14, 15) .
The non-subtype specific anti-cholinergic oxybutynin and M3-specific anti-cholinergic darifenacin reduce afferent firing during bladder filling (16, 17) . This may result from direct desensitisation of afferents, but an alternative hypothesis that they reduce the release of ATP from mucosa (urothelium and sub-urothelium) when the tissue is stressed is supported by two lines of evidence: i.
Muscarinic receptor activation by non-subtype specific agonists increased intracellular calcium and evoked ATP release in cultured rat urothelial cells (18) ; ii. Intravesical instillation of a non-subtype specific agonist increased voiding frequency in an in vivo rat preparation (19) . In order to bridge the gap between isolated cells and whole animal, we measured stretch-induced ATP release from 4 mucosal preparations in the absence and presence of two muscarinic receptor antagonists that have some selectivity for M3 or M2 subtypes. Two strips (6 -8 mm long and 2 -3 mm wide) were cut along the craniocaudal axis.
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MATERIALS AND METHODS
Preparation
Stretch of mucosa strips. Strips were tied at either end using fine silk suture (7/0; Pearsalls, UK) and then transferred to a horizontal organ bath, where one end was tied to a fixed hook and the other to the arm of an isometric tension transducer (FT03D; Grass instruments, USA) connected to a bridge amplifier (TBM-4M; WPI, UK). Preparations were continuously superfused (10 ml.min -1 ) with fresh, gassed Ca 2+ -free Tyrode's and allowed to equilibrate at a slack length (0 mN tension) for one hour prior to each experiment. Following equilibration, preparations were stretched to a constant tension over <5 seconds by driving the micromanipulator arm holding the force transducer.
Preparations equilibrated for a further one hour during which time the tension relaxed to near prestretch values. The strips were then superfused with 4-DAMP (10 nM), methoctramine (1 μM) or vehicle (0.1 % DMSO or 0.1 % water, respectively) for 20 minutes, after which preparations were again stretched to a similar tension. After a further 30 minutes' superfusion, preparations were rapidly relaxed by cutting one of the suture ties holding the tissue. Sampling of superfusate. Samples (100 μl) were taken at fixed time points during the above protocol, immediately prior to, and following, mechanical (stretch, relaxation) or pharmacological Statistical analysis. n a refers to the number of animals and n s the number of mucosal strips. To calculate the rate of change in tension over time, traces were integrated, taking the minimum value as baseline, using Chart software (v. experiments and shows that the stretch protocol and the quantity of ATP release were consistent. In the presence of 10 nM 4-DAMP, the stretch-induced increase of [ATP] was abolished and the concentration was actually significantly reduced to 61% of pre-stretch levels (P<0.05; n s =5, n a =5; Figure 2 ).
Methoctramine vs. vehicle.
A similar finding was recorded in the presence of 1 μM methoctramine.
In the presence of vehicle alone, stretch increased [ATP] to 1750% of pre-stretch levels.
Methoctramine abolished the stretch-induced increase of ATP and reduced [ATP] to 20% of control (P<0.05; n s =5, n a =5; Figure 2 ).
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Rapid relaxation and ATP release. Thirty minutes after the final stretch in the presence or absence of an anti-cholinergic agent, the suture holding the mucosa strip to the force transducer arm was cut and tension reduced rapidly to zero. In all preparations there was a large increase of ATP immediately after tension reduction. Figure 3 
DISCUSSION
We show that stretch of guinea pig bladder mucosa strips induced about a three-fold release of ATP, which was abolished by the muscarinic receptor antagonists 4-DAMP and methoctramine.
Relaxation of the strips also released ATP, to a far greater extent than stretch. The mucosa strips were quite sensitive to mechanical disturbance, as bathing with superfusate also evoked some release of ATP, and this was taken into account in our experiments. We therefore have three important observations, each of which is discussed below.
We demonstrate that alteration of resting tension is the key determinant of ATP release: (i) [ATP] increases in response to a rapid tensioning and (ii) returns to baseline concentrations following relaxation approximately one hour later. We chose to stretch mucosal strips to a consistent increase of resting tension rather than to a similar percentage of resting length (4, 20) . The large range of length changes (122-222% of original) required to achieve consistent tension changes implies that the passive mechanical properties of the mucosa will influence stretch-induced ATP release. Thus there was no correlation between percentage change in strip length and the amount of ATP released.
Secondly, rapid relaxation of mucosal strips also stimulated significant ATP release suggesting that change in tension, rather than the magnitude of change, is at least as important for this phenomenon. Application of negative pressure to isolated detrusor myocytes increased the opening probability of a Gd 3+ -sensitive ion channel, but there was no indication of an 'off' response (21) and thus is different from the observations above with the mucosal preparations. However, urothelium has a range of stretch-dependent modalities that regulate ATP release, including epithelial Na channels (ENaC; 1,22,23), Gd 3+ sensitive pathways (24) and TRP channels (24, 25) . The directional sensitivity and relative importance of these different routes remain to be evaluated.
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Finally we showed that muscarinic receptor antagonists methoctramine and 4-DAMP inhibit stretch-induced ATP release from guinea pig mucosa. These experiments build on previous demonstrations that muscarinic agonists stimulate ATP release from urothelial cells (13) and increasing voiding frequency in an anaesthetised rat (19) , to complete a circle in showing that stretch-induced release of ATP from the mucosa is muscarinic receptor-dependent.
The concentrations used were chosen to demonstrate a proof-of-principle for an effect of anticholinergic agents on ATP release; each agent was used at a concentration at least 10-fold greater than the pK i value for the primary subtype and approximately equal to the pK i for the secondary subtype; i.e. 4-DAMP was used at 10 nM with M3 and M2 pK i values 9.3 and 8.1; methoctramine used at 1 μM with M2 and M3 pK i values 7.7 and 6.0 (26, 27) . Further experiments will be required to determine the subtype that exerts a more significant effect on ATP release.
Of interest was the observation that in several experiments ATP release in the presence of 4-DAMP or methoctramine was less than baseline levels and consistent with an endogenous release of acetylcholine before stretch was induced. This finding is in disagreement with that of Kullmann et al. (19) in which intravesical instillation of atropine had no effect on voiding parameters in rats, suggesting inter-preparation or inter-species differences.
Our data add to the evidence that anti-cholinergic agents used to treat human lower urinary tract pathologies act on mucosal muscarinic receptors and is consistent with the clinical observations that these agents act more on OAB symptoms associated with filling rather than voiding (15) . They also support the hypothesis that their action in reducing bladder sensations of bladder filling is not only on afferent desensitisation (16, 17) , but also limits stress-induced ATP release itself.
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Conclusions. M2/M3 muscarinic receptor antagonism inhibits stretch-evoked ATP release from bladder mucosa. This novel interaction of these drugs and ATP has important implications for the treatment of over-active bladder. . n s =20, n a =10.
Figures
